Imatinib mesylate associated with delayed hematopoietic recovery after concomitant chemotherapy.

Chand, M

Imatinib mesylate associated with delayed hematopoietic recovery after concomitant chemotherapy. [electronic resource] - Leukemia Apr 2004 - 886-7; author reply 887-8 p. digital

Publication Type: Case Reports; Comment; Letter

0887-6924

10.1038/sj.leu.2403311 doi


Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Benzamides
Hematopoiesis--drug effects
Humans
Imatinib Mesylate
Leukemia, Myeloid, Chronic-Phase--drug therapy
Lymphoma, B-Cell--drug therapy
Lymphoma, Follicular
Male
Neoplasms, Second Primary--drug therapy
Piperazines--adverse effects
Pyrimidines--adverse effects